CLNT [Cleantech Solutions International,] 8-K: (Original Filing)

[China Wind Systems, Inc. Reports Second Quarter 2010 Results -- Second quarter 2010 revenues increased 39.7% to $19.0 million -- Net income increased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, Inc. (Nasdaq: Second Quarter 2010 Highlights and Recent Events -- Net revenue increased 39.7%]

CLNT [Cleantech Solutions International,] 8-K: China Wind Systems, Inc. Reports Second Quarter 2010

[China Wind Systems, Inc. Reports Second Quarter 2010 Results -- Second quarter 2010 revenues increased 39.7% to $19.0 million -- Net income increased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, Inc. (Nasdaq: Second Quarter 2010 Highlights and Recent Events -- Net revenue increased 39.7%]

CLNT [Cleantech Solutions International,] 8-K: (Original Filing)

[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]

CLNT [Cleantech Solutions International,] 8-K: China Wind Systems, Reports Second Quarter 2010 Results

[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:09:01+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4%

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:10:24+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

NFEC [NF Energy Saving] 10-Q/A: FORM 10-Q/A x for the Quarterly Period Ended

[FORM 10-Q/A x for the Quarterly Period Ended June 30, 2010 o for the Transition Period from _______ to _______ NF Energy Saving Corporation Delaware 02-0563302 (State or Other Jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 21-Jia Bei Si Dong Road, Tie Xi Qu Shenyang, P. R. China 110021 (8624) 2560-9750 x o o o Large accelerated filer] [Certifications I, Gang, Li, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of NF Energy Saving Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certifications I, Li Hua Wang, certify that: 1. I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of NF Energy Saving Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the six months ended June 30, 2010 . NF Energy Saving Corporation Gang Li ( EX-32.1 4 v194168_ex32-1.htm] [SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the six months ended June 30, 2010. NF Energy Saving Corporation Principal Financial and Accounting Officer) ( EX-32.2 5 v194168_ex32-2.htm]

CNET [ChinaNet Online] 8-K: (Original Filing)

[ChinaNet Online Holdings Reports Record Second Quarter 2010; Net Income grew 223% to $4.2 Million with Diluted EPS of $0.20 Results underscore significant progress in ChinaNet becoming a leading B2B Internet advertising solutions provider · Revenues increased 28% in the second quarter, driven by an 87% increase in Internet Advertising · Net income grew 223% YOY to $4.2 million, with]

By | 2016-03-05T01:43:38+00:00 August 17th, 2010|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments

CNET [ChinaNet Online] 8-K: ChinaNet Online Holdings Reports Record Second Quarter 2010;

[ChinaNet Online Holdings Reports Record Second Quarter 2010; Net Income grew 223% to $4.2 Million with Diluted EPS of $0.20 Results underscore significant progress in ChinaNet becoming a leading B2B Internet advertising solutions provider · Revenues increased 28% in the second quarter, driven by an 87% increase in Internet Advertising · Net income grew 223% YOY to $4.2 million, with]

By | 2016-03-05T01:45:28+00:00 August 17th, 2010|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue From Continuing Operations in Second Quarter Fiscal Year 2010 Gross Margin Remains of 53%; $0.33 Diluted Earnings Per Share; Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million XI’AN, CHINA – August 17, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2010 Highlights · Revenue increases]

By | 2016-03-01T05:52:26+00:00 August 17th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar